Eve is a Market Access director at Putnam. She holds a PhD in Health economics, a Pharm.D. and a Master’s Degree in Pharmaco-Epidemiology.
During her 9+ years of experience in the field of market access, Eve has managed several types of market access projects in different therapeutic areas, including the development of market access strategies, value propositions, evidence generation plans, and the preparation of early advices. Eve has acquired proficient knowledge on HTA, pricing and reimbursement processes and health policy at global level. Her area of expertise is gene and cell therapies HTA, funding and market access.
She is a co-author of a book and several publications in peer-reviewed journals and major conferences, all focused on gene and cell therapies.